CervoMed CRVO
NASDAQ CRVO
$2.34 +0.05 (+2.18%)
At close: Oct 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) EV to CFO (2023)

Updated

CervoMed's EV to CFO came in at -3.01 for Q2 2023.

Analysis

CervoMed (CRVO) EV to CFO (2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2023, CervoMed reported EV to CFO of -25.06.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CervoMed 23.77 Mn -62.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -3.01
Mar 31, 2023 -13.59
API Access

CervoMed EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CRVO&period=max&api_key=YOUR_API_KEY